Nephrotic syndrome trials in United States

In United States 21 Also abroad 66

21 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.

Phase 2Not yet taking people in United States
Effects of Meal Macronutrients on Postprandial Lipids
Where
Bethesda
Age
18 years to 120 years
People
100
Run by
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
See details and how to joinNCT07313787
No phaseTaking people
Immune System Related Kidney Disease
Where
Bethesda
Age
10 years to 99 years
People
2,000
Run by
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
See details and how to joinNCT00001979
Phase 2Taking people
A Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease
Where
Albuquerque, Ann Arbor, Atlanta, Birmingham, Chapel Hill, Chicago, Cleveland, Dallas, Edina, El Paso, Hinsdale, Houston, Las Vegas, New York, Orange, San Francisco, Tampa, The Bronx
Age
16 years to 75 years
People
84 worldwide
Run by
Sanofi
See details and how to joinNCT06500702
No phaseTaking people
Pediatric Longitudinal Glomerular Disease: a PNRC Multi-Institutional Cohort Study
Where
Boston, Cincinnati
Age
Up to 18 years
People
1,000
Run by
Pediatric Nephrology Research Consortium
See details and how to joinNCT07931170
No phaseTaking people
Nephrotic Syndrome Study Network
Where
Ann Arbor, Atlanta, Aurora, Baltimore, Bethesda, Chapel Hill, Charleston, Charlotte, Chicago, Cleveland, Columbus, Dallas, Houston, Kansas City, Los Angeles, Miami, New Hyde Park, New York, Palo Alto, Philadelphia, Rochester, San Francisco, Seattle, Spokane, St Louis, The Bronx, Torrance, Winston-Salem
Age
Up to 80 years
People
1,200 worldwide
Run by
University of Michigan
See details and how to joinNCT01209000
No phaseTaking people
NEPTUNE Match Study
Where
Ann Arbor, Atlanta, Baltimore, Chapel Hill, Charlotte, Chicago, Cleveland, Kansas City, New Hyde Park, New York, Philadelphia, Seattle, Spokane
Age
1 year to 80 years
People
375
Run by
University of Michigan
See details and how to joinNCT04571658
Phase 2Taking people
An Open-Label Phase 2 Study of N-Acetyl-D-Mannosamine (ManNAc) in Subjects With Podocyte Diseases
Where
Bethesda
Age
18 years to 115 years
People
30
Run by
National Human Genome Research Institute (NHGRI)
See details and how to joinNCT06664814
No phaseTaking people
Diuretic Tuner Clinical Decision Support
Where
Dallas
Age
18 years and over
People
30
Run by
University of Texas Southwestern Medical Center
See details and how to joinNCT04759274
Phase 2Taking people
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
Where
Bethesda
Age
18 years to 90 years
People
30
Run by
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
See details and how to joinNCT00977977
No phaseEnrolling by invitation
Clinical Phenotyping Resource and Biobank Core of the Michigan O'Brien Renal Center
Where
Ann Arbor, Charlotte, Detroit, Philadelphia
People
1,800
Run by
University of Michigan
See details and how to joinNCT01016613
Phase 2Taking people
Belimumab With Rituximab for Primary Membranous Nephropathy
Where
Ann Arbor, Aurora, Baltimore, Bethesda, Birmingham, Chapel Hill, Cleveland, Columbus, Jacksonville, Little Rock, Miami, Minneapolis, New York, Omaha, Philadelphia, San Francisco, Spokane, Stanford, St Louis, Torrance
Age
18 years to 75 years
People
58
Run by
National Institute of Allergy and Infectious Diseases (NIAID)
See details and how to joinNCT03949855
No phaseTaking people
Natural History of Sphingosine Phosphate Lyase Insufficiency Syndrome (SPLIS)
Where
San Francisco
People
28
Run by
University of California, San Francisco
See details and how to joinNCT06669949
Phase 2Taking people
Study of WAL0921 in Patients With Glomerular Kidney Diseases
Where
Atlanta, Dakota Dunes, Denver, Hinsdale, Houston, Los Angeles, San Antonio, Tamarac
Age
18 years to 75 years
People
96 worldwide
Run by
Walden Biosciences
See details and how to joinNCT06466135
Phase 2Taking people
Atacicept in Multiple Glomerular Diseases
Where
Brisbane
Age
2 years and over
People
250
Run by
Vera Therapeutics, Inc.
See details and how to joinNCT06983028
Phase 2Taking people
Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases
Where
Ann Arbor, Boston, Chapel Hill, Charlotte, Columbus, Durham, Hackensack, Houston, Iowa City, Kansas City, Los Angeles, Miami, Minneapolis, Neptune City, New Hyde Park, New York, Oklahoma City, Philadelphia, Seattle, Wilmington
Age
1 year to 17 years
People
67 worldwide
Run by
Travere Therapeutics, Inc.
See details and how to joinNCT05003986 · EU 2023-505497-14-00
No phaseTaking people
Recurrence Post-transplant Observational Study in Focal Segmental Glomerulosclerosis and Minimal Change Disease
Where
Ann Arbor
People
300
Run by
University of Michigan
See details and how to joinNCT05650619
No phaseTaking people
A Pilot Trial of taVNS for SRNS in Children (kidNEY-VNS)
Where
New Hyde Park, Philadelphia
Age
3 years to 17 years
People
10
Run by
Northwell Health
See details and how to joinNCT05583942
No phaseTaking people
taVNS for FRNS in Children
Where
New Hyde Park, Philadelphia
Age
3 years to 17 years
People
30
Run by
Northwell Health
See details and how to joinNCT05588063
No phaseNot yet taking people in United States
SLIT ABS: Study on Patients With Autoimmune Podocytopathy
Where
Rochester
Age
0 years to 99 years
People
50 worldwide
Run by
Meyer Children's Hospital IRCCS
See details and how to joinNCT07516964
No phaseTaking people
Interview Study of Adult and Child Patients and Parents of Children With Swelling Due to Nephrotic Syndrome.
Where
Ann Arbor
Age
2 years and over
People
150
Run by
University of Michigan
See details and how to joinNCT05505500
No phaseTaking people
SPL Insufficiency Syndrome (SPLIS)/NPHS14: a SPLIS Observational Study and Patient Registry (International)
Where
San Francisco
People
120
Run by
University of California, San Francisco
See details and how to joinNCT04885179